G. M. White, Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris, J Am Acad Dermatol, vol.39, pp.34-37, 1998.

M. P. Law, A. A. Chuh, A. Lee, and N. Molinari, Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong, Clin Exp Dermatol, vol.35, pp.16-21, 2010.

H. C. Williams, R. P. Dellavalle, and S. Garner, Acne vulgaris, Lancet, vol.379, pp.361-72, 2012.

A. L. Dawson and R. P. Dellavalle, Acne vulgaris, BMJ, vol.346, p.2634, 2013.

J. I. Silverberg and N. B. Silverberg, Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. populationbased study, Br J Dermatol, vol.170, pp.1136-1178, 2014.

W. J. Cunliffe and D. J. Gould, Prevalence of facial acne vulgaris in late adolescence and in adults, Br Med J, vol.1, pp.1109-1119, 1979.

V. Goulden, G. I. Stables, and W. J. Cunliffe, Prevalence of facial acne in adults, J Am Acad Dermatol, vol.41, pp.577-80, 1999.

C. N. Collier, J. C. Harper, and J. A. Cafardi, The prevalence of acne in adults 20 years and older, J Am Acad Dermatol, vol.58, pp.56-59, 2008.

K. Bhate and H. C. Williams, Epidemiology of acne vulgaris, Br J Dermatol, vol.168, pp.474-85, 2013.

G. L. Peck, T. G. Olsen, and F. W. Yoder, Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid, N Engl J Med, vol.300, pp.329-362, 1979.

G. L. Peck, T. G. Olsen, and D. Butkus, Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study, J Am Acad Dermatol, vol.6, pp.735-780, 1982.

H. Jones, D. Blanc, and W. J. Cunliffe, 13-cis retinoic acid and acne, Lancet, vol.2, pp.1048-1097, 1980.

D. H. Jones, K. King, A. J. Miller, and W. J. Cunliffe, A dose-response study of I3-cis-retinoic acid in acne vulgaris, Br J Dermatol, vol.108, pp.333-376, 1983.

D. H. Jones and W. J. Cunliffe, Remission rates in acne patients treated with various doses of 13-cis-retinoic acid (isotretinoin), Br J Dermatol, vol.111, pp.123-148, 1984.

J. S. Strauss, R. P. Rapini, and A. R. Shalita, Isotretinoin therapy for acne: results of a multicenter dose-response study, J Am Acad Dermatol, vol.10, pp.490-96, 1984.

L. Cleach, L. Lebrun-vignes, B. Bachelot, and A. , French Acne Guidelines Working Group and Centre of Evidence of Dermatology. Guidelines for the management of acne: recommendations from a French multidisciplinary group, Br J Dermatol, vol.177, pp.908-921, 2017.

H. Autorité-de-santé, Practice Guideline on the Treatment of Acne, 2015.

A. Nast, B. Dréno, and V. Bettoli, European evidence-based (S3) guideline for the treatment of acne-update 2016-short version, J Eur Acad Dermatol Venereol, vol.30, p.1261, 2016.

A. L. Zaenglein, A. L. Pathy, and B. J. Schlosser, Guidelines of care for the management of acne vulgaris, J Am Acad Dermatol, vol.74, pp.945-73, 2016.

C. J. Roman, A. S. Cifu, and S. L. Stein, Clinical guidelines for management of acne vulgaris-reply, JAMA, vol.317, p.213, 2017.

F. W. Rosa, Teratogenicity of isotretinoin, Lancet, vol.2, p.513, 1983.

U. S. , The iPLEDGE Program Guide To Best Practices For Isotretinoin, 2019.

, Pregnancy Prevention Programme, Agence Nationale de Sécurité des Médicaments et des produits de santé (ANSM), 2019.

G. U. , H1, Pregnancy Prevention Programme, vol.6, 2013.

U. S. , Food and Drug Administration (FDA), 2010.

, Medication Guide of Risk Minimization Measures, Agence Nationale de Sécurité des Médicaments et des produits de santé (ANSM), 2015.

. U. Gov and . Guidance, Isotretinoin for Severe Acne: Uses and Effects, 2014.

G. U. , Public Assessment Review, 2014.

D. K. Wysowski, M. Pitts, and J. Beitz, An analysis of reports of depression and suicide in patients treated with isotretinoin, J Am Acad Dermatol, vol.45, pp.515-534, 2001.

J. D. Bremner, K. D. Shearer, and P. J. Mccaffery, Retinoic acid and affective disorders: the evidence for an association, J Clin Psychiatry, vol.73, pp.37-50, 2012.

M. A. Gupta and A. K. Gupta, Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis, Br J Dermatol, vol.139, pp.846-50, 1998.

D. Purvis, R. E. Merry, S. Watson, and P. , Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students, J Paediatr Child Health, vol.42, pp.793-96, 2006.

F. Dalgard, U. Gieler, J. Ø. Holm, E. Bjertness, and S. Hauser, Self-esteem and body satisfaction among late adolescents with acne: results from a population survey, J Am Acad Dermatol, vol.59, pp.746-51, 2008.

J. A. Halvorsen, R. S. Stern, F. Dalgard, M. Thoresen, E. Bjertness et al., Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a populationbased study, J Invest Dermatol, vol.131, pp.363-70, 2011.

L. Misery, Consequences of psychological distress in adolescents with acne, J Invest Dermatol, vol.131, p.290, 2011.

M. A. Gupta, A. K. Gupta, and B. Vujcic, Increased frequency of Attention Deficit Hyperactivity Disorder (ADHD) in acne versus dermatologic controls: analysis of an epidemiologic database from the US, J Dermatolog Treat, vol.25, pp.115-133, 2014.

L. Misery, P. Wolkenstein, and J. Amici, Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based study, Acta Derm Venereol, vol.95, pp.485-88, 2015.

S. Ramrakha, D. M. Fergusson, and L. J. Horwood, Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study, Br J Dermatol, vol.175, pp.1079-81, 2016.

S. S. Jick and H. M. Kremers, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide, Arch Dermatol, vol.136, pp.1231-1267, 2000.

K. Hersom, M. P. Neary, H. P. Levaux, W. Klaskala, and J. S. Strauss, Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis, J Am Acad Dermatol, vol.49, pp.424-456, 2003.

T. Friedman, Y. Wohl, and H. Y. Knobler, Increased use of mental health services related to isotretinoin treatment: a 5-year analysis, Eur Neuropsychopharmacol, vol.16, p.413, 2006.

L. Azoulay, L. Blais, G. Koren, J. Lelorier, and A. Bérard, Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study, J Clin Psychiatry, vol.69, pp.526-558, 2008.

A. Sundströ-m, L. Alfredsson, G. Sjö-lin-forsberg, B. Gerdén, U. Bergman et al., Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study, BMJ, vol.341, p.5812, 2010.

P. Tuppin, J. Rudant, and P. Constantinou, Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France, Rev Epidemiol Sante Publique, vol.65, pp.149-67, 2017.

A. Palmaro, G. Moulis, F. Despas, J. Dupouy, and M. Lapeyre-mestre, Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies, Fundam Clin Pharmacol, vol.30, pp.616-640, 2016.

S. Suissa, The case-time-control design, Epidemiology, vol.6, pp.248-53, 1995.

A. Government, Therapeutic Goods Administration. Medicines Safety Update, vol.7, 2016.

Y. C. Huang and Y. C. Cheng, Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis, J Am Acad Dermatol, vol.76, pp.1068-76, 2017.

J. D. Bremner, N. Fani, and A. Ashraf, Functional brain imaging alterations in acne patients treated with isotretinoin, Am J Psychiatry, vol.162, p.1614, 2005.

J. D. Bremner and P. Mccaffery, The neurobiology of retinoic acid in affective disorders, Prog Neuropsychopharmacol Biol Psychiatry, vol.32, pp.315-346, 2008.

S. Schneeweiss, T. Stü-rmer, and M. Maclure, Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research, Pharmacoepidemiol Drug Saf, vol.6, pp.51-59, 1997.

S. Suissa, The case-time-control design: further assumptions and conditions, Epidemiology, vol.9, pp.441-486, 1998.

M. Maclure and M. A. Mittleman, Should we use a casecrossover design?, Annu Rev Public Health, vol.21, pp.193-221, 2000.

P. S. Wang, S. Schneeweiss, R. J. Glynn, H. Mogun, and J. Avorn, Use of the case-crossover design to study prolonged drug exposures and insidious outcomes, Ann Epidemiol, vol.14, pp.296-303, 2004.

M. Bigby, Does isotretinoin increase the risk of depression?, Arch Dermatol, vol.144, pp.1234-1239, 2008.

S. M. Langan and J. M. Batchelor, Acne, isotretinoin and suicide attempts: a critical appraisal, Br J Dermatol, vol.164, pp.1185-86, 2011.

D. J. Margolis, Commentary: acne, isotretinoin and suicide attempts, Br J Dermatol, vol.164, pp.1186-87, 2011.